|
Volumn 47, Issue S62, 2013, Pages 55-76
|
SCAAR annual report 2011
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CLOPIDOGREL;
CONTRAST MEDIUM;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
FONDAPARINUX;
HEPARIN;
HIRULOG;
LOW MOLECULAR WEIGHT HEPARIN;
PRASUGREL;
TICAGRELOR;
TIROFIBAN;
ACUTE CORONARY SYNDROME;
ANGIOCARDIOGRAPHY;
ANTICOAGULANT THERAPY;
ARTICLE;
BARE METAL STENT;
BLEEDING;
CARDIOVASCULAR RISK;
CLINICAL DECISION MAKING;
COMPUTER ASSISTED TOMOGRAPHY;
CONTRAST ENHANCEMENT;
CORONARY ARTERY OBSTRUCTION;
CORONARY STENT;
DRUG ELUTING STENT;
GERIATRIC PATIENT;
HEALTH CARE UTILIZATION;
HUMAN;
INTRAVASCULAR ULTRASOUND;
ISCHEMIC HEART DISEASE;
NEUROLOGICAL COMPLICATION;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
PUNCTURE;
RADIATION DOSE;
RISK ASSESSMENT;
ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
SWEDEN;
TREATMENT INDICATION;
ADULT;
AGED;
AGED, 80 AND OVER;
ANNUAL REPORTS AS TOPIC;
CORONARY ANGIOGRAPHY;
FEMALE;
HEART DISEASES;
HUMANS;
MALE;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
QUALITY OF HEALTH CARE;
REGISTRIES;
SEVERITY OF ILLNESS INDEX;
SWEDEN;
TIME FACTORS;
|
EID: 84882313246
PISSN: 14017431
EISSN: 16512006
Source Type: Journal
DOI: 10.3109/14017431.2013.779835 Document Type: Article |
Times cited : (3)
|
References (0)
|